AbstractABSTRACT INTRODUCTION : Prostate cancer is forth most common diagnosed tumors in Malaysian male. The use of a self-reported, quality of life assessment is important for clinical practice, care taker and researcher to evaluate the level of quality of life. OBJECTIVES: The aim of this study was to measure the internal consistency of the translated Malay Language EORTC QLQ-C30 and EORTC PR-25 questionnaires among prostate cancer patient at National University of Malaysia hospital in Kuala Lumpur, Malaysia. METHODS: This was a cross sectional study conducted between July 2017 and Dec 2017. The respondent was comprised of 110 Malaysian prostate cancer patients who under follow up at Urology and Oncology Clinic. Sets of translated Malay language EORTC QLQ C30 and EORTC PR-25 were administered to assess their quality of life consisted of functional, symptom and global health status domains. RESULTS: The translated questionnaires were acceptable by 110 respondents. The study also showed that there were significant findings in the symptom of constipation and bowel among prostate cancer patients and no significant difference of global health status and quality of life score comparing stages of cancer disease and type of treatment. Cronbach`s α coefficient result were 0.913 (EORTC QLQ-C30) and 0.829 (EORTC PR-25) respectively suggested that this instrument had good internal consistency. CONCLUSIONS: Our study confirmed that translated Malay language EORTC QLQ-C30 and QLQ-PR25 questionnaires are acceptable, reliable and valid instrument to be used among Malaysian prostate cancer patients. KEYWORD: Quality of Life – EORTC QLQ C30 – EORTC PR-25 –prostate cancer – Malay language
The international Agency for Research on Cancer.Prostate Cancer Incidence and Mortality Worldwide in 2008.Summary.Globocan,2010.
World Health Organization (2014) www.who.int/cancer/country-profiles/mys
Gerard CCL (2003). Cancer in Malaysia -there is light at the end of the tunnel. Med J Malaysia, 58, 632-5.
World Health Organization. (1978). The constitution of the world health organization.Geneva:WHO
Van Andel G, Bottomley A, Fossa S et al (2008) An international field study of the EORTC QLQ-PR 25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer.Eur J cancer 44:2418-2424
Efficace F,Bottomley A, van Andel G. (2003) Health related quality of life in prostate carcinoma patients:a systematic review of randomized controlled trials. Cancer ;97:377-88.
Litwin MS. (2003). Quality of life following definitive therapy for localized prostate cancer:potential impact of multiple therapies.Curr Opin Urol ;13:152-6.
Lubeck DP, Grossfeld GD,Carroll PR. (2001) The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer.Urology ;58(2 Supp 1):94-100
Litwin MS, Gore JL, Kwan L, et al. (2007) Quality of life after surgery, external beam irradiation,or brachytherapy for early-stage prostate cancer. Cancer ;109:2239-47.
Wyler SF, Engeler DS, Seelentag W, et al. (2009) Health-related quality of life after radical prostatectomy and low-dose-rate brachytherapy for localized prostate cancer. Urol Int ;82:17-23.
Cull A, Sprangers M, Bjordal K, Aaronson N, on behalf of the EORTC Quality of Life Study Group. (1998) EORTC Quality of Life Study Group Translation Procedure. EORTC, Brussels, . ISBN: 2-930064-15-3.
Fayers P, Aaronson N, Bjordahl K, et al: (2001) The EORTC QLQ-C30 scoring Manual. 3rd edition. European Organization for Cancer Research and Treatment of Cancer, Brussels.
Cronbach LJ (1951) Coefficient alpha and the internal structure of tests.Psychometrika 16:297
DeVellis R.F (2003). Scale development: Theory and application (2nd Ed).Thousand Oaks, CA:SAGE
Arraras JI,Villafranca E,de la Vega FA,et al. (2008) The EORTC quality of life questionnaires QLQ-C30(version 3.0).Validation study for Spanish prostate cancer patients. Arch Esp Urol ;61:949-54.
Arraras JI,Villafranca E,de la Dega FA,et al. (2009) The EORTC quality of life questionnaire for patient with prostate cancer: EORTC QLQ-PR25.Validation study for Spanish patients.Clin Trans Oncol 11:160-4
W.C Chie ,C.C Yu, H.J Yu. (2010). Reliability and Validity of the Taiwan Chinese Version of the EORTC QLQ-PR25 in Assessing Quality of Life of Prostate Cancer Patients.Urol Sci 21(3):118-125
Costello A.B & Osborne J.W (2005). Best practice in Exploratory factor Analysis:Four Recommendation for Getting the Most from Your Analysis.Practical Assesment Research & Evaluation. 10(7):1-9
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.